BAY524

CAS No. 1445830-39-6

BAY524 ( —— )

Catalog No. M22177 CAS No. 1445830-39-6

BAY-524 is an inhibitor of Bub1(IC50 = 450 nM.human Bub1 in the presence of 2 mM ATP).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 295 Get Quote
10MG 498 Get Quote
25MG 804 Get Quote
50MG 1098 Get Quote
100MG 1485 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BAY524
  • Note
    Research use only, not for human use.
  • Brief Description
    BAY-524 is an inhibitor of Bub1(IC50 = 450 nM.human Bub1 in the presence of 2 mM ATP).
  • Description
    BAY-524 is an inhibitor of Bub1(IC50 = 450 nM.human Bub1 in the presence of 2 mM ATP).
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Bub1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1445830-39-6
  • Formula Weight
    482.48
  • Molecular Formula
    C24H24F2N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:150 mg/mL?(310.89 mM;?Need ultrasonic)
  • SMILES
    CCOc1cc(F)c(Cn2nc(c(C)c2OC)-c2ncc(OC)c(Nc3ccncc3)n2)c(F)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Baron AP, et al. Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524. Elife. 2016 Feb 17;5. pii: e12187.
molnova catalog
related products
  • Perflubron

    Perflubron can be emulsified with egg phospholipids (EYP) and displays exceptionally fast excretion characteristics.

  • PF-04859989 HCl

    PF-04859989 HCl is a brain-penetrable and irreversible inhibitor of kynurenine amino transferase II (KAT II), which is the enzyme responsible for most of the brain synthesis of kynurenic acid.

  • 3,4-Dimethoxycinnami...

    3, 4-Dimethoxycinnamic acid, previously identified in plasma after coffee consumption, was rapidly absorbed in the free form most likely by passive diffusion in the upper gastrointestinal tract.